LIGAND PHARMACEUTICALS INC ($LGND)
Filing Information
| Accession Number | 0002001011-26-000114 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 14, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
19,414
Total Value
$2,406,537.36
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Aug 12, 2026 | Exercise/Conversion | 6,138 | $51.56 | $316,475.28 | 11,119 | Direct | โ | View Details | |
Director | Common Stock | โ | Aug 12, 2026 | Sale | 7,138 | $292.81 | $2,090,062.08 | 3,981 | Direct | โ | View Details | |
Director | Non-Qualified Stock Option (right to buy) | Derivative | Aug 12, 2026 | Exercise/Conversion | 6,138 | $0.00 | $0.00 | 0 | Direct | โ | View Details |